How can functional hyperconnectivity patterns distinguish compensatory mechanisms from early pathological markers in AD?
PARTIALLY ADDRESSED
The debate framework identified functional hyperconnectivity as potentially representing either compensatory responses or early pathological changes, but this critical distinction remains unresolved. Determining which interpretation is correct would fundamentally alter therapeutic targeting strategies and early intervention approaches.
Source: Debate session sess_SDA-2026-04-04-frontier-connectomics-84acb35a (Analysis: SDA-2026-04-04-frontier-connectomics-84acb35a)
Landscape Summary:
How can functional hyperconnectivity patterns distinguish compensatory mechanisms from early pathological markers in AD? is a 0.9 priority gap in neurodegeneration.
It has 0 linked hypotheses with average composite score 0.000.
Status: partially_addressed.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
How can functional hyperconnectivity patterns distinguish compensatory mechanisms from early pathological markers in AD? — INVOKE-2 (completed)